The Ultimate Interface for Drug Discovery: How Spatial Computing and AI Agents Are Transforming How We Understand Molecules

This presentation features Steve McCloskey, founder and chief executive officer, Nanome who discusses the incorporation of AI and virtual reality (VR) into drug-discovery tools and how it is not likely to replace current technologies, but rather to enhance them.

Register or Login and hit Watch on Demand to view the recorded presentation now.